Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
Clinical trial NCT02845713 · COMPLETED
Trial details
- NCT number
- NCT02845713
- Sponsor
- University Hospitals Cleveland Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-17
- Primary completion
- 2016-06-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.